Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wael A Alghamdi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|May 27, 2026
Clinical Use of Bayesian Model-Informed Precision Dosing in Routine Practice: A Focused Systematic ReviewWael A Alghamdi
Healthcare (Basel, Switzerland)|October 27, 2022
Comparison of Saudi Pharmacist Licensure Examination (SPLE) Pass Rates by Institution and Applicant CharacteristicsWael A Alghamdi, Tahani M Almeleebia, Khalid M Orayj
Therapeutic Drug Monitoring|November 16, 2020
Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples"Mohammad H Al-Shaer, Wael A Alghamdi, Charles Peloquin
Antimicrobial Agents and Chemotherapy|May 9, 2018
Protein Binding of First-Line Antituberculosis DrugsWael A Alghamdi, Mohammad H Al-Shaer, Charles A Peloquin
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 29, 2024
Factors associated with applicant performance on the Saudi Pharmacist Licensure Examination (SPLE)Wael A Alghamdi, Tahani M Almeleebia, Mona A Almanasef, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2021
Comment on: The case for 'conservative pharmacotherapy'Abdullah Alsultan, Mohammad H Al-Shaer, Wael A Alghamdi, et al.
Therapeutic Drug Monitoring|July 19, 2019
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient SamplesMohammad H Al-Shaer, Wael A Alghamdi, Emily Graham, et al.
Clinical Case Reports|July 23, 2020
Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case seriesWael A Alghamdi, Mohammad H Al-Shaer, Kenneth P Klinker, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2019
A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C TreatmentRussell R Kempker, Wael A Alghamdi, Mohammad H Al-Shaer, et al.
Expert Review of Clinical Pharmacology|August 15, 2017
Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Omamah Alfarisi, Wael A Alghamdi, Mohammad H Al-Shaer, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|May 27, 2026
Clinical Use of Bayesian Model-Informed Precision Dosing in Routine Practice: A Focused Systematic ReviewWael A Alghamdi
Healthcare (Basel, Switzerland)|October 27, 2022
Comparison of Saudi Pharmacist Licensure Examination (SPLE) Pass Rates by Institution and Applicant CharacteristicsWael A Alghamdi, Tahani M Almeleebia, Khalid M Orayj
Therapeutic Drug Monitoring|November 16, 2020
Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples"Mohammad H Al-Shaer, Wael A Alghamdi, Charles Peloquin
Antimicrobial Agents and Chemotherapy|May 9, 2018
Protein Binding of First-Line Antituberculosis DrugsWael A Alghamdi, Mohammad H Al-Shaer, Charles A Peloquin
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 29, 2024
Factors associated with applicant performance on the Saudi Pharmacist Licensure Examination (SPLE)Wael A Alghamdi, Tahani M Almeleebia, Mona A Almanasef, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2021
Comment on: The case for 'conservative pharmacotherapy'Abdullah Alsultan, Mohammad H Al-Shaer, Wael A Alghamdi, et al.
Therapeutic Drug Monitoring|July 19, 2019
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient SamplesMohammad H Al-Shaer, Wael A Alghamdi, Emily Graham, et al.
Clinical Case Reports|July 23, 2020
Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case seriesWael A Alghamdi, Mohammad H Al-Shaer, Kenneth P Klinker, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2019
A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C TreatmentRussell R Kempker, Wael A Alghamdi, Mohammad H Al-Shaer, et al.
Expert Review of Clinical Pharmacology|August 15, 2017
Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Omamah Alfarisi, Wael A Alghamdi, Mohammad H Al-Shaer, et al.
Pageof 4